Total medical devices industry deals for Q4 2019 worth $13.75bn were announced globally, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 25.02% over the previous quarter and a drop of 8.1% when compared with the last four-quarter average of $14.97bn.
In terms of number of deals, the sector saw a drop of 2.4% over the last four-quarter average with 373 deals against the average of 382 deals.
In value terms, Europe led the activity with deals worth $5.72bn.
Medical devices industry deals in Q4 2019: Top deals
The top five medical devices deals accounted for 66.4% of the overall value during Q4 2019.
The combined value of the top five medical devices deals stood at $9.13bn, against the overall value of $13.75bn recorded for the month.
The top five medical devices industry deals of Q4 2019 tracked by GlobalData were:
1) Stryker’s $5.4bn acquisition of Wright Medical Group
2) The $1.55bn asset transaction with Hitachi by Fujifilm
3) Baring Private Equity Asia’s $1bn private equity deal with Lumenis
4) The $650m private equity deal with 3M by Altaris Capital Partners
5) Laborie Medical Technologies’ acquisition of Clinical Innovations for $525m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.